We are live on ! Find out more
EXFY icon

Expensify

109 hedge funds and large institutions have $45M invested in Expensify in 2025 Q4 according to their latest regulatory filings, with 16 funds opening new positions, 36 increasing their positions, 38 reducing their positions, and 12 closing their positions.

New
Increased
Maintained
Reduced
Closed

1,613% more call options, than puts

Call options by funds: $137K | Put options by funds: $8K

33% more first-time investments, than exits

New positions opened: 16 | Existing positions closed: 12

4% more funds holding

Funds holding: 105109 (+4)

5% less repeat investments, than reductions

Existing positions increased: 36 | Existing positions reduced: 38

2.82% less ownership

Funds ownership: 39.69%36.87% (-2.8%)

24% less capital invested

Capital invested by funds: $59.1M → $45M (-$14.1M)

Holders
109
Holders Change
+4
Holders Change %
+3.81%
% of All Funds
1.33%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
16
Increased
36
Reduced
38
Closed
12
Calls
$137K
Puts
$8K
Net Calls
+$129K
Net Calls Change
-$59K
Name Holding Trade Value Shares
Change
Change in
Stake
Vanguard Group
1
Vanguard Group
Pennsylvania
$7.06M +$209K +132,107 +3%
BlackRock
2
BlackRock
New York
$6.15M -$137K -86,207 -2%
Acadian Asset Management
3
Acadian Asset Management
Massachusetts
$3.27M -$161K -101,547 -4%
Ameriprise
4
Ameriprise
Minnesota
$2.8M +$28.1K +17,737 +1%
CM
5
CastleKnight Management
New York
$2.61M -$683K -431,243 -20%
Marshall Wace
6
Marshall Wace
United Kingdom
$2.17M +$122K +76,833 +6%
PVM
7
Palogic Value Management
Texas
$2.12M +$745K +470,078 +50%
Geode Capital Management
8
Geode Capital Management
Massachusetts
$2.12M -$10.4K -6,563 -0.5%
D.E. Shaw & Co
9
D.E. Shaw & Co
New York
$2.04M -$281K -177,243 -12%
Connor, Clark & Lunn Investment Management (CC&L)
10
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
$1.48M -$160K -100,786 -9%
FG
11
Formula Growth
Quebec, Canada
$1.36M -$396K -250,000 -22%
State Street
12
State Street
Massachusetts
$1.08M +$64.1K +40,445 +6%
Renaissance Technologies
13
Renaissance Technologies
New York
$1.03M -$38.4K -24,250 -3%
Morgan Stanley
14
Morgan Stanley
New York
$802K -$206K -130,036 -20%
IC
15
IEQ Capital
California
$729K -$45.6K -28,785 -6%
Charles Schwab
16
Charles Schwab
California
$677K -$548 -346 -0.1%
Northern Trust
17
Northern Trust
Illinois
$631K -$52.1K -32,856 -7%
Two Sigma Investments
18
Two Sigma Investments
New York
$560K +$155K +97,583 +36%
Goldman Sachs
19
Goldman Sachs
New York
$444K -$48.5K -30,576 -9%
Two Sigma Advisers
20
Two Sigma Advisers
New York
$399K +$31.9K +20,100 +8%
Qube Research & Technologies (QRT)
21
Qube Research & Technologies (QRT)
United Kingdom
$399K -$134K -84,451 -24%
Bank of New York Mellon
22
Bank of New York Mellon
New York
$353K +$100K +63,385 +37%
XT
23
XTX Topco
Cayman Islands
$289K +$16.1K +10,150 +6%
ETC
24
Exchange Traded Concepts
Oklahoma
$262K -$164K -103,647 -37%
AQR Capital Management
25
AQR Capital Management
Connecticut
$243K -$151K -95,104 -37%

EXFY Hedge Fund Activity: Q4 2025 in Review

109 of the 8,223 institutional investors tracked by Wall St. Rank reported a position in Expensify (EXFY) for Q4 2025, worth a combined $45M — down 24% from $59.1M a quarter earlier.

Buyers outnumbered sellers: 16 funds opened new EXFY positions and 12 closed out — a net gain of 4 holders — while 36 added to existing stakes and 38 trimmed.

The largest buyer was Palogic Value Management, adding an estimated $745K. The largest seller was Ceera Investments, exiting entirely with an estimated $821K sold.

  • 109 institutional investors held Expensify (EXFY) as of Q4 2025, up from 105 in Q3 2025.
  • Funds reported $45M of Expensify stock for Q4 2025, down 24% quarter-over-quarter.
  • 16 funds opened new Expensify positions in Q4 2025 and 12 closed out, a net change of +4 holders.
  • The largest Expensify buyer in Q4 2025 was Palogic Value Management, an estimated $745K added.
  • The largest Expensify seller in Q4 2025 was Ceera Investments, an estimated $821K sold.

Based on aggregated 13F filings for Q4 2025.